These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1890206)

  • 21. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
    Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
    J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature.
    McIlwain L; Sokol L; Moscinski LC; Saba HI
    Eur J Haematol; 2003 Apr; 70(4):242-5. PubMed ID: 12656749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia.
    Boughton BJ; Franklin IM; Apperley J; Knight D
    Br J Haematol; 1984 Oct; 58(2):378-80. PubMed ID: 6591946
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of antifungal therapy on hematological recovery after intensive antileukemic chemotherapy.
    Essink ME; Hiddemann W; von Eiff M; Büchner T; van de Loo J
    Haematol Blood Transfus; 1990; 33():558-9. PubMed ID: 2323655
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose daunorubicin in older patients with acute myeloid leukemia.
    Löwenberg B; Ossenkoppele GJ; van Putten W; Schouten HC; Graux C; Ferrant A; Sonneveld P; Maertens J; Jongen-Lavrencic M; von Lilienfeld-Toal M; Biemond BJ; Vellenga E; van Marwijk Kooy M; Verdonck LF; Beck J; Döhner H; Gratwohl A; Pabst T; Verhoef G; ; ;
    N Engl J Med; 2009 Sep; 361(13):1235-48. PubMed ID: 19776405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myxoedema in a case of acute myeloid leukaemia.
    Grützmeier S
    Scand J Haematol; 1985 Apr; 34(4):323-5. PubMed ID: 3858981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.
    Pilorge S; Rigaudeau S; Rabian F; Sarkozy C; Taksin AL; Farhat H; Merabet F; Ghez S; Raggueneau V; Terré C; Garcia I; Renneville A; Preudhomme C; Castaigne S; Rousselot P
    Am J Hematol; 2014 Apr; 89(4):399-403. PubMed ID: 24375467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group.
    Ruutu T; Almqvist A; Hallman H; Honkanen T; Järvenpää E; Järventie G; Koistinen P; Koivunen E; Lahtinen R; Lehtinen M
    Leukemia; 1994 Jan; 8(1):11-5. PubMed ID: 8289475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient.
    Ikeda Y; Sakemi T; Matsuzaki M; Sano M
    Intern Med; 2002 Sep; 41(9):722-4. PubMed ID: 12322800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
    Schiller G; Gajewski J; Lee M; Ho W; Territo M; Champlin R
    Leuk Lymphoma; 1994 Sep; 15(1-2):85-90. PubMed ID: 7858506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
    Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
    Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J
    Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
    Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
    Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
    Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
    Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
    [No Abstract]   [Full Text] [Related]  

  • 37. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
    Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
    Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
    Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
    Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
    [No Abstract]   [Full Text] [Related]  

  • 39. The blast crisis of chronic granulocytic leukaemia: a new approach to treatment.
    Schey SA; Greene ML; Ardeman S; Ruddell K
    Br J Haematol; 1985 Jan; 59(1):190-2. PubMed ID: 3855645
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.